TrialThe American journal of pathology2010

Multiplexed assessment of the Southwest Oncology Group-directed Intergroup Breast Cancer Trial S9313 by AQUA shows that both high and low levels of HER2 are associated with poor outcome.

Malini Harigopal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.